SpringerLink
Log in

Natural killer cells and autoimmunity

  • Natural Killer Cells
  • Published:
Immunologic Research Aims and scope Submit manuscript

Summary

In various autoimmune diseases it appears that NK activity is impaired, and that this phenomenon is significant in disease development. Impairment of NK activity may be the result of two different mechanisms. In systemic autoimmune diseases, in which various target organs are involved (nonorgan-specific), the peripheral blood NK level is generally lower than normal (table 2). This most likely allows the expression of autoimmune phenomena such as B cell hyperactivity and polyclonal antibody production, as is seen in SLE, due to a defect in the termination of the immune response. In autoimmune diseases with more localized, organ-specific lesions one can detect increased NK activity at the target organ itself (table 3). In these instances, the cytotoxic characteristic of the NK cell is more prominent. This theory explains why both increased and decreased NK activity may be observed in autoimmune diseases. In some disorders in which decreased NK activity was suspected of being crucial, immunomodulators, known to increase NK activity, were administered. Yet it is still difficult to separate the NK activity from the effect of the remaining immune system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Takasugi M, Mickey MR, Terasaki PI: Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res 1973;33:2898–2902.

    PubMed  CAS  Google Scholar 

  2. Herberman RB, Gaylord CE: Conference and workshop on cellular immune reactions to human tumor-associated antigens. Natl Cancer Inst Monogr 1973;37:1–121.

    Google Scholar 

  3. Oldham RK, Siwarski D, McCoy JL, et al.: Evaluation of a cell-mediated cytotoxicity assay utilizing125I-iododeoxyuridine-labelled tissue-culture target cells. Natl Cancer Inst Monogr 1973;37:49–58.

    PubMed  CAS  Google Scholar 

  4. Grimm E, Bonavida B: Mechanism of cell-mediated cytotoxicity at the single cell level. J Immunol 1979;123:2861–2869.

    PubMed  CAS  Google Scholar 

  5. Ullberg M, Jondal M: Recycling and target binding capacity of human natural killer cells. J Exp Med 1981;153:615–628.

    Article  PubMed  CAS  Google Scholar 

  6. Gastl G, Niederwieser D, Marth C, et al.: Human large granular lymphocytes and their relationship to natural killer cell activity in various disease states. Blood 1984;64:288–295.

    PubMed  CAS  Google Scholar 

  7. Timonen T, Sakgela E, Rarki A, et al.: Fractionation morphologic and functional characterization of effector cells responsible for human natural activity against live cell targets. Cell Immunol 1979;48:133–148.

    Article  PubMed  CAS  Google Scholar 

  8. Bloom B: Natural killers to rescue immune surveillance? Nature 1982;300:214–215.

    Article  PubMed  CAS  Google Scholar 

  9. Timonen T, Ortaldo JR, Herberman RB: Analysis by a single cell cytotoxicity assay of natural killer cell; frequencies among human large lymphocytes and of the effects of interferon on their activity. J Immunol 1982;128:2514–2521.

    PubMed  CAS  Google Scholar 

  10. Djeu JY, Timonen T, Herberman RB: Production of interferon by human natural killer cells in response to mitogens viruses and bacteria; in Herberman RB (ed): NK Cells and Other Natural Effector Cells. New York, Academic Press, 1982, pp 669–674.

    Google Scholar 

  11. Gorelik E, Wiltrout RM, Okumura K, et al.: Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Int J Cancer 1982; 30:107–112.

    Article  PubMed  CAS  Google Scholar 

  12. Sibbit WL, Bankhurst AD: Natural killer cells in connective tissue disorders. Clin Rheum Dis 1985;11:507–521.

    Google Scholar 

  13. Schwartz RS, Stollar BD: Origins of anti-DNA autoantibodies. J Clin Invest 1985;75:321–327.

    Article  PubMed  CAS  Google Scholar 

  14. Takeuchi T, Abe T, Kiyotuki M, et al.: In vitro immune response of SLE lymphocytes. The mechanism involved in B cell activation. Scand J Immunol 1982;16:369–377.

    Article  PubMed  CAS  Google Scholar 

  15. Ytterberg SR, Schnitzer TJ: Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum 1982;25:401–406.

    Article  PubMed  CAS  Google Scholar 

  16. Abruzzo LV, Rowley DA: Homeostasis of the antibody responses: immunoregulation by NK cells. Science 1983;222:581–585.

    Article  PubMed  CAS  Google Scholar 

  17. Nabel G, Allard WJ, Cantor HA: Cloned cell line mediated natural killer cell function inhibits immunoglobulin secretion. J Exp Med 1982;156 658–663.

    Article  PubMed  CAS  Google Scholar 

  18. Arai S, Yamamoto H, Itoh K: Suppressive effect of human natural killer cells on pokeweed mitogen induced B cell differentiation. J Immunol 1983;131:651–657.

    PubMed  CAS  Google Scholar 

  19. Herberman RB, Holden HT: Natural killer cells as antitumor effector cells. J Natl Cancer Inst. 1979; 62:441–444.

    PubMed  CAS  Google Scholar 

  20. Silverman SL, Cathcart ES: Natural killing in systemic lupus erythematosis. Inhibitory effects of serum. Clin Immunol Immunopathol 1980;17: 219–226.

    Article  PubMed  CAS  Google Scholar 

  21. Sibbitt WL, Mathews PM, Bankhurst AD: Natural killer cell in systemic lupus erythematosis. Defects in effector lytic activity and response to interferon and interferon inducers. J Clin Invest 1983;71: 1230–1239.

    Article  PubMed  Google Scholar 

  22. Egan ML, Mendelson SL, Abo T, et al.: Natural killer cells in systemic lupus erythematosus abnormal number and functional immaturity of HNK-1 cells. Arthritis Rheum 1983;26:623–629.

    Article  PubMed  CAS  Google Scholar 

  23. Gonzalez-Amaro R, Alcocer-Varela J, Alarcon-Segovia D: Natural killer cell activity in the systemic connective tissue diseases. J Rheumatol 1988;15:1223–1228.

    PubMed  CAS  Google Scholar 

  24. Goto T, Tanimoto K, Horivchi Y: Natural cell mediated cytotoxicity in systemic lupus erythematosus suppression by antilymphocyte antibody. Arthritis Rheum 1980;23:1274–1281.

    Article  PubMed  CAS  Google Scholar 

  25. Sibbit WL, Mathews PM, Bankhurst AD: Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus. Arthritis Rheum 1984;27:1095–1100.

    Article  Google Scholar 

  26. Sibbit WL Jr, Froelich CJ, Bankhurst AD: Interferon alpha regulation of lymphocyte function in systemic lupus erythematosus. Clin Immunol Immunopathol 1984;32:70–80.

    Article  Google Scholar 

  27. Ytterberg SR, Huard TK, Schnitzer TJ: Effects of serum from patients with systemic lupus erythematosus on leukocyte cytotoxicity modulation of NK activity and ADU. J Rheumatol 1983;10: 906–912.

    PubMed  CAS  Google Scholar 

  28. Ytterberg SR, Schnitzer TJ: Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus. Roles of disease activity and serum interferon. Ann Rheum Dis 1984; 43:457–461.

    Article  PubMed  CAS  Google Scholar 

  29. Rook AH, Tsokos GL, Quinnan GV: Cytotoxic antibodies to natural killer cells in systemic lupus erythematosus. Clin Immunol Immunopathol 1982;24:179–185.

    Article  PubMed  CAS  Google Scholar 

  30. Alcocer-Varela J, Alarcon-Segovia D: Decreased production of response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 1982;69:1388–1392.

    Article  PubMed  CAS  Google Scholar 

  31. Tsokos GL, Smith PL, Christian CB, et al.: Interleukin-2 restores the depressed allogeneic cell mediated lympholysis and natural killer cell activity in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1985;34:379–386.

    Article  PubMed  CAS  Google Scholar 

  32. Sibbit WL Jr, Likar L, Spellman CW, et al: Impaired natural killer cell activity in systemic lupus erythematosus relationship to interleukin 2 production. Arthritis Rheum 1983;26:1316–1320.

    Article  Google Scholar 

  33. Sibbit WL Jr, Gibbs DL, Kenny L, et al.: Relationship between circulating interferon and anti-interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus. Arthritis Rheum 1985;28:624–629.

    Article  Google Scholar 

  34. Neighbour PA, Grayzel AI: Interferon production in vitro by leukocytes from patients with systemic lupus erythematosus and rheumatoid arthritis. Clin Exp Immunol 1981;25:576–582.

    Google Scholar 

  35. Riccardi C, Vose BM, Herberman RB: Modulation of IL-2 dependent growth of mouse NK cells by interferon and T lymphocytes. J Immunol 1983;130:228–232.

    PubMed  CAS  Google Scholar 

  36. Sibbit WL Jr, Froelich CJ, Bankhurst AD: Abnormal interferon modulation of natural cytotoxicity in systemic lupus erythematosus relation to suppressive serum factors. Arthritis Rheum 1983;26: 1452–1459.

    Article  Google Scholar 

  37. Talal N: Interleukins, interferon and rheumatic disease. Clin Rheum Dis 1985;11:633–644.

    PubMed  CAS  Google Scholar 

  38. Raedler A, Bredow G, Kirch W, et al.: In vivo activated peripheral T cells in autoimmune disease. J Clin Lab Immunol 1986;19:181–186.

    PubMed  CAS  Google Scholar 

  39. Pederson BK, Beyer JM, Klarlund K, et al.: Baseline and interferon enhanced natural killer cell activity in rheumatoid arthritis. Acta Pathol Microbiol Immunol Scand C 1985;93:79–84.

    Google Scholar 

  40. Fantini F, Valenti F, Mercuriali F, et al.: Impaired natural killing activity in patinets with rheumatoid arthritis. Clinical characteristics and a study of defective mechanisms. Boll Ist Sieroter Milan 1986;65:40–46.

    PubMed  CAS  Google Scholar 

  41. Combe B, Pope R, Darnell B, et al.: Modulation of natural killer cell activity in the rheumatoid joint and peripheral blood. Scand J Immunol 1984;20: 551–558.

    Article  PubMed  CAS  Google Scholar 

  42. Goto M, Zvaifler NJ: Characterization of the natural killer like lymphocytes in rheumatoid synovial fluid. J Immunol 1985;134:1483–1486.

    PubMed  CAS  Google Scholar 

  43. Eales LJ, Goulding NJ, Hall ND, et al.: Lymphocytes bearing Fc gamma receptors in rheumatoid arthritis. III. Immunoregulatory function associated with Facb rosette forming cells. Ann Rheum Dis 1985;44:8–12.

    Article  PubMed  CAS  Google Scholar 

  44. Tovar Z, Pope RM, Talal N: Modulation of spontaneous immunoglobulin products by natural killer cells in rheumatoid arthritis. Arthritis Rheum 1986;29:1435–1439.

    Article  PubMed  CAS  Google Scholar 

  45. Reinitz E, Neighbour PA, Grayzel AI: Natural killer cell activity of mononuclear cells from rheumatoid patients measured by a conjugate binding cytotoxicity assay. Arthritis Rheum 1982;25: 1440–1444.

    Article  PubMed  CAS  Google Scholar 

  46. Malejczyk J, Kaminski MJ, Malejczyk M, et al: Natural cell mediated cytotoxic activity against isolated chondrocytes in the mouse. Clin Exp Immunol 1985;59:110–116.

    PubMed  CAS  Google Scholar 

  47. Pederson BK, Beger JM, Rasmussen A, et al: Methyl prednisolone pulse therapy induced fall in natural killer cell activity in rheumatoid arthritis. Acta Pathol Microbiol Immunol Scand C 1984; 92:319–323.

    Google Scholar 

  48. Pederson BK, Beyer JM, Rasmussen A, et al.: Azothioprine as single drug in the treatment of rheumatoid arthritis induces complete suppression of natural killer cell activity. Acta Pathol Microbiol Immunol Scand C 1984;92:221–225.

    Google Scholar 

  49. Ausiello CM, Barbieri P, Spagnoli GC, et al: In vivo effects of chloroquine treatment of spontaneous and interferon induced natural killer activities in rheumatoid arthritis patients. Clin Exp Rheumatol 1986;4:255–259.

    PubMed  CAS  Google Scholar 

  50. Ohara M, Igarashi S, Kobashi C, et al.: The effects of the antirheumatic agents N-(2-carboxyphenyl)-4-chloranthranilic acid disodium CCA andD-penicillamine on the NK and ADCC activities and interferon production of lymphocytes. J Immunopharmacol 1984;6:163–172.

    Article  PubMed  CAS  Google Scholar 

  51. Forre O, Theon J, Natvig JB: Effects of nonsteroidal antiinflammatory drugs on the immune network. Semin Arthritis Rheum 1983;13(suppl 1): 130–133.

    Article  PubMed  CAS  Google Scholar 

  52. McCheshey MB, Bankhurst AD: Cytotoxic mechanisms in vitro against Epstein Barr virus infected lymphoblastoid cell lines in rheumatoid arthritis. Ann Rheum Dis 1986;45:546–552.

    Article  Google Scholar 

  53. Pederson BD, Oxholm P, Manthrope P: Interleukin-2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome. Clin Exp Immunol 1986;63:1–7.

    Google Scholar 

  54. Minato N, Takeda A, Kano S, et al.: Studies of the function of natural killer interferon system in patients with Sjögren's syndrome. J Clin Invest 1982;69:581–588.

    Article  PubMed  CAS  Google Scholar 

  55. Pederson BK, Oxholm P: Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndrome. Clin Exp Immunol 1988;72:299–302.

    Google Scholar 

  56. Fox FI, Adamson TC, Fong S, et al.: Characterization of the phenotype and function of lymphocytes infiltrating the salivary gland in patients with primary Sjögren's syndrome. Diagn Immunol 1983;1:233–239.

    PubMed  CAS  Google Scholar 

  57. Fox RI, Hugli TE, Lanier LL, et al.: Salivary gland lymphocytes in primary Sjögren's syndrome lack lymphocytes subsets defined by leu-7 and leu-11 antigens. J Immunol 1985;135:207–214.

    PubMed  CAS  Google Scholar 

  58. Wright JK, Hughos P, Rowell NR: Spontaneous lymphocyte mediated (NK cell) cytotoxicity in systemic sclerosis a comparison with antibody dependent lymphocytes (k cell) cytotoxicity. Ann Rheum Dis 1982;41:409–413.

    Article  PubMed  CAS  Google Scholar 

  59. Hooks JJ, Moutsopoulos HM, Notkins AL: The role of interferon in immediate hypersensitivity and autoimmune diseases. Ann NY Acad Sci 1980;350:21–32.

    Article  PubMed  CAS  Google Scholar 

  60. Wright JK, Hughes P, Rowell NR: Lymphocyte cytotoxicity in systemic sclerosis: no increase on short-term culture with established cell lines. Ann Rheum Dis 1982;41:414–416.

    Article  PubMed  CAS  Google Scholar 

  61. Armstrong RD, Panayi GS: Natural killer cell activity in inflammatory joint disease. Clin Rheumatol 1983;2:243–249.

    Article  PubMed  CAS  Google Scholar 

  62. Vinje D, Forre D, Degre M: Natural killer cell activity of peripheral blood lymphocytes from patients with Bechterew's syndrome (ankylosing spondylitis). Scand J Rheumatol 1984;13:297–302.

    Article  PubMed  CAS  Google Scholar 

  63. Kaneko F, Takahashi Y, Muramatsu R, et al.: Natural killer cell numbers and function in peripheral lymphoid cells in Behcet's disease. Br J Dermatol 1985;113:313–318.

    Article  PubMed  CAS  Google Scholar 

  64. Levisky RJ, Lehner T: Circulating soluble immune complexes in recurrent oral ulcers in Behcet's syndrome. Clin Exp Immunol 1978;32:193–198.

    Google Scholar 

  65. Reimer G, Steinkohl S, Djawari D, et al.: Lytic effects of cytotoxic lymphocytes on epithelial cells in Behcet's disease. Br J Dermatol 1982;107:529–536.

    Article  PubMed  CAS  Google Scholar 

  66. Majewski S, Wasik M, Jablinska A, et al.: Defective natural killer and killer cell activity associated with increased polymorphonuclear leukocyte adherence in psorias. Arch Dermatol Res 1986;278: 264–269.

    Article  PubMed  CAS  Google Scholar 

  67. Stern R, Tieler S, Parrish P: Psoriasis and the risk of cancer. J Invest Dermatol 1982;78:147–149.

    Article  PubMed  CAS  Google Scholar 

  68. Miller ML, Lantner R, Pachman LM: Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis. J Rheumatol 1983;10:640–642.

    PubMed  CAS  Google Scholar 

  69. Gonzalez-Amaro R, Alcocer-Varela J, Alarcon-Segovia D: Natural killer cell activity in dermatomyositis polymyositis. J Rheumatol 1987;14:307–310.

    PubMed  CAS  Google Scholar 

  70. Gonzalez-Amaro R, Alcocer-Varela J, Martinez-Cordero E, et al: Natural killer cell mediated activity in mixed connective tissue disease and its response to induction by interleukin-2. J Clin Immunol 1984;4:273–279.

    Article  PubMed  CAS  Google Scholar 

  71. James SP, Jones EA: Abnormal natural killer cytotoxicity in primary biliary cirrhosis: evidence for a functional deficiency of cytolytic effector cells. Gastroenterology 1985;89:165–171.

    PubMed  CAS  Google Scholar 

  72. Sedmak DD, Hart WR, Tubbs RR: Autoimmune oophoritis: A histopathologic study of involved ovaries with immunologic characterization of the mononuclear cell infiltrate. Int J Gynecol Pathol 1987;6:73–81.

    Article  PubMed  CAS  Google Scholar 

  73. Aohi K, Yamada H, Takai M, et al.: Natural killer activity and antibody dependent cell mediated cytotoxicity in primary glomerular diseases. Clin Nephrol 1987;27:11–14.

    Google Scholar 

  74. Thyss A, Caldani C, Bourcier C, et al: Deficiency of NK activity evolving in a parallel manner with immune granulopenia. Clin Exp Immunol 1989; 76:317–323.

    Google Scholar 

  75. Partanen S, Ruutu T, Vvopio P, et al: Acquired pure red-cel aplasia: A consequence of increased natural killer cell activity. Leuk Res 1984;8:117–122.

    Article  PubMed  CAS  Google Scholar 

  76. Jakobiec FA, Lefkowitch J, Knowles DM: B and T lymphocytes in ocular disease. Ophthalmology 1984;91:635–654.

    PubMed  CAS  Google Scholar 

  77. Sorokin AM, Kovalchuck LV, Tunkel OI, et al: Interferon producing and cytotoxic activity of natural killer cells in multiple sclerosis patients. Zh Nevropatol Psikhiatr 1987;87:211–215.

    PubMed  CAS  Google Scholar 

  78. Olsson T, Holmda WR, Klareskog L, et al: Dynamics of Ia expressing cells and T lymphocytes of different subsets during experimental allergic neuritis in Lewis rats. J Neurol Sci 1984;66:141–149.

    Article  PubMed  CAS  Google Scholar 

  79. Nair MP, Lewis EW, Schwartz SA: Immunoregulatory dysfunctions in type 1 diabetes: natural and antibody dependent cellular cytotoxic activities. J Clin Immunol 1986;6:363–372.

    Article  PubMed  CAS  Google Scholar 

  80. Aichinger G, Fill H, Wick G: In situ immune complexes lymphocyte subpopulations and HLA-DR positive epithelial cells in Hashimoto thyroiditis. Lab Invest 1985;52:132–140.

    PubMed  CAS  Google Scholar 

  81. Wang PW, Hiromatsu Y, Largen E, et al: Immunologically mediated cytotoxicity against human eye muscle cells in Grave's ophthalmopathy. J Clin Endocrinol Metab 1986;63:316–322.

    PubMed  CAS  Google Scholar 

  82. Delisi LE, Crow TJ: Is schizophrenia a viral or immunologic disorder? Psychiatr Clin North Am 1986;9:115–132.

    PubMed  CAS  Google Scholar 

  83. Waksman BH, Reynolds WE: Multiple sclerosis as a disease of immune regulation. Proc Soc Exp Biol Med 1984;175:282–294.

    PubMed  CAS  Google Scholar 

  84. Hirsch RL, Johnson KP: The effect of recombinant alpha-2-interferon on defective natural killer cell activity in multiple sclerosis. Neurology 1985; 35:597–600.

    PubMed  CAS  Google Scholar 

  85. Naighbour PA: Studies of interferon production and natural killing by lymphocytes from multiple sclerosis patients. Ann NY Acad Sci 1984;436: 181–191.

    Article  Google Scholar 

  86. Hirsch RL, Johnson KP: Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-alpha 2. Clin Immunol Immunopathol 1985;37:236–244.

    Article  PubMed  CAS  Google Scholar 

  87. Coaccioli S, Brunetti P, Puxeddu A: Altered distribution of lymphocyte subpopulations in type 1 diabetes mellitus. Ital J Med 1985;1:8–13.

    Google Scholar 

  88. Wilson RG, Anderson J, Shenton BK, et al: Natural killer cells in insulin dependent diabetes mellitus. Br Med J [Clin Res] 1986;293:244.

    CAS  Google Scholar 

  89. Gupta S, Charles MA, Waldeck N, et al: Multiparameter immunologic studies in patients with newly diagnosed type 1 insulin dependent diabetes mellitus. Diabetes Res 1986;3:225–229.

    PubMed  CAS  Google Scholar 

  90. Negishi K, Waldeck N, Chandy G, et al: Natural killer cell and islet killer cell activities in type 1 (insulin dependent) diabetes. Diabetologia 1986; 29:352–357.

    Article  PubMed  CAS  Google Scholar 

  91. Cancy KG, Charles MA, Buckingham B, et al: Deficiency of monoclonal antibody (leu 7) defined NK cells in newly diagnosed insulin dependent diabetes mellitus. Immunol Lett 1984;8:89–91.

    Article  Google Scholar 

  92. Richens ER, Jones WG: T lymphocyte subpopulations in type 1 diabetes mellitus. A longitudinal study. Acta Diabetol Lat 1985;22:229–238.

    Article  PubMed  CAS  Google Scholar 

  93. Yoyota T, Satoh J, Ova K, et al.: Streptococcal preparation (OK 432) inhibits development of type 1 diabetes in NOD mice. Diabetes 1986;35: 496–499.

    Google Scholar 

  94. Rayfield EJ, Ault M, Keusch G, et al: Infection and diabetes. The case for glucose control. Am J Med 1982;72:439–450.

    Article  PubMed  CAS  Google Scholar 

  95. Kessler I: Cancer and diabetes mellitus: A review of the literature. J Chronic Dis 1971;23:579–600.

    Article  PubMed  CAS  Google Scholar 

  96. Sack J, Baker JR, Weetman AP, et al: Killer cell activity and antibody dependent cell mediated cytotoxicity are normal in Hashimoto's disease. J Clin Endocrinol Metab 1986;62:1059–1064.

    Article  PubMed  CAS  Google Scholar 

  97. Papic M, Stein-Streilein J, Zakarija M, et al: Suppression of peripheral blood natural killer cell activity by excess thyroid hormone. J Clin Invest 1987;79:404–408.

    Article  PubMed  CAS  Google Scholar 

  98. Iwatani Y, Amino N, Kabutomori O, et al: Decrease of peripheral large granular lymphocytes in Grave's disease. Clin Exp Immunol 1984;55:239–234.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Units of Autoimmune Diseases, Department of Medicine, Soroka Medical Center, Beer Sheva, Israel

    Eyal Grunebaum, Elinor Malatzky-Goshen & Yehuda Shoenfeld

  2. Department of Medicine B, Chaim Sheba Medical Center, 52621, Tel-Hashomer, (Israel)

    Eyal Grunebaum, Elinor Malatzky-Goshen & Yehuda Shoenfeld

Authors
  1. Eyal Grunebaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elinor Malatzky-Goshen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yehuda Shoenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported in part by a grant from Mr. Toby Green (London, UK).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grunebaum, E., Malatzky-Goshen, E. & Shoenfeld, Y. Natural killer cells and autoimmunity. Immunol Res 8, 292–304 (1989). https://doi.org/10.1007/BF02935514

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02935514

Keywords

Search

Navigation